207 related articles for article (PubMed ID: 37795995)
1. Colorectal cancer-associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations.
Cao Y; Wang J; Hou W; Ding Y; Zhu Y; Zheng J; Huang Q; Cao Z; Xie R; Wei Q; Qin H
Gut Microbes; 2023 Dec; 15(2):2263934. PubMed ID: 37795995
[TBL] [Abstract][Full Text] [Related]
2. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
[TBL] [Abstract][Full Text] [Related]
3. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
4.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
7. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
8.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
9. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps.
Liang S; Mao Y; Liao M; Xu Y; Chen Y; Huang X; Wei C; Wu C; Wang Q; Pan X; Tang W
Int J Biol Sci; 2020; 16(1):135-146. PubMed ID: 31892851
[No Abstract] [Full Text] [Related]
11. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
12. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
13. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.
Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R
Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635
[TBL] [Abstract][Full Text] [Related]
15. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
16. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer.
Xing J; Liao Y; Zhang H; Zhang W; Zhang Z; Zhang J; Wang D; Tang D
Front Cell Infect Microbiol; 2022; 12():804689. PubMed ID: 35493741
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
18. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
19. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
Yeoh YK; Chen Z; Wong MCS; Hui M; Yu J; Ng SC; Sung JJY; Chan FKL; Chan PKS
Gut; 2020 Nov; 69(11):1998-2007. PubMed ID: 32051205
[TBL] [Abstract][Full Text] [Related]
20. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]